Palian HRD Gene Detection

Genetic screening for hereditary cancer susceptibility genes including BRCA and other tumor suppressors. This test enables early identification of high-risk individuals for surveillance.

A diagnostic kit for detecting IDH1 R132H mutations in glioma patient tissue samples. It achieves high sensitivity detecting mutations as low as 1% in 10ng/μL samples with specificity exceeding 99%. The results are provided with clear data output and objective interpretation without subjective judgment. It enables convenient operation allowing detection of 90 samples in a single run within 1 hour while maintaining a compact system design with minimal contamination risk.

A molecular diagnostic kit for DPYD mutation detection. Used in pharmacogenomics and oncology for identifying dihydropyrimidine dehydrogenase gene mutations.

Diagnostic test for identifying genetic disorders through molecular analysis of biological samples. The test can detect chromosomal abnormalities and inherited genetic conditions.

A molecular detection kit for identifying hereditary disease markers and genetic predispositions. Designed for clinical screening and diagnostic purposes in genetic medicine applications.

A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.

A diagnostic kit for the detection of IDH1 and IDH2 mutations. Used in oncology and haematology for identifying isocitrate dehydrogenase gene alterations associated with various malignancies.

A diagnostic assay for detection of KRAS mutations in colorectal and other cancers using PNA-based technology for precision medicine applications.

A molecular assay for the detection of specific genetic sequences or mutations in patient samples. The test is used in genetic screening, disease diagnosis, and personalized medicine applications.

Digital PCR-based assay for detecting single-copy genes and rare mutations in clinical samples. Provides absolute quantification without standard curve requirements.

A molecular diagnostic kit for detecting and differentiating IDH1 and IDH2 mutations. Designed for comprehensive identification and characterization of IDH mutations in oncology and haematology applications.

In vitro diagnostic kit for detecting EGFR gene mutations in patient samples. Enables molecular profiling of epidermal growth factor receptor status to guide targeted cancer therapy selection and treatment planning in oncology.